Please ensure Javascript is enabled for purposes of website accessibility
Home / News / Government Federal / FDA panels vote in favor of stronger Yaz warnings

FDA panels vote in favor of stronger Yaz warnings

Two federal advisory panels voted earlier this month in favor of requiring Bayer AG to update warning labels on its popular birth control drug Yaz to reflect new concerns of an increased risk of blood clots. The Dec. 8 joint meeting of the panels was sponsored by the U.S. Food and Drug Administration and held in ...